The potential of liquid biopsy in the management of cancer patients

A Markou, E Tzanikou, E Lianidou - Seminars in cancer biology, 2022 - Elsevier
Over the last decade, liquid biopsy has gained much attention as a powerful tool in
personalized medicine, since it enables monitoring cancer evolution and follow-up of cancer …

Clinical applications of the CellSearch platform in cancer patients

S Riethdorf, L O'Flaherty, C Hille, K Pantel - Advanced drug delivery …, 2018 - Elsevier
Abstract The CellSearch® system (CS) enables standardized enrichment and enumeration
of circulating tumor cells (CTCs) that are repeatedly assessable via non-invasive “liquid …

DNA damage response and resistance of cancer stem cells

E Abad, D Graifer, A Lyakhovich - Cancer Letters, 2020 - Elsevier
The cancer stem cell (CSC) model defines tumors as hierarchically organized entities,
containing a small population of tumorigenic CSC, or tumour-initiating cells, placed at the …

Microfluidic technologies for circulating tumor cell isolation

H Cho, J Kim, H Song, KY Sohn, MH Jeon, KH Han - Analyst, 2018 - pubs.rsc.org
Metastasis is the main cause of tumor-related death, and the dispersal of tumor cells through
the circulatory system is a critical step in the metastatic process. Early detection and analysis …

Functional implications of the dynamic regulation of EpCAM during epithelial-to-mesenchymal transition

TC Brown, NV Sankpal, WE Gillanders - Biomolecules, 2021 - mdpi.com
Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein expressed in
epithelial tissues. EpCAM forms intercellular, homophilic adhesions, modulates epithelial …

[HTML][HTML] EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy

I Chebouti, S Kasimir-Bauer, P Buderath… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background Assuming that tumor cell dissemination requires a shift to a mesenchymal
phenotype, we analyzed the incidence of epithelial-to-mesenchymal-transition (EMT)-like …

Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer …

A Strati, M Nikolaou, V Georgoulias, ES Lianidou - Cells, 2019 - mdpi.com
(1) Background: The aim of the study was to evaluate the prognostic significance of EMT-
associated (TWIST1) and stem-cell (SC) transcript (CD24, CD44, ALDH1) quantification in …

RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patients

C Keup, P Mach, B Aktas, M Tewes… - Clinical …, 2018 - academic.oup.com
BACKGROUND Liquid biopsies are discussed to provide surrogate markers for therapy
stratification and monitoring. We compared messenger RNA (mRNA) profiles of circulating …

Gene expression signatures in circulating tumor cells correlate with response to therapy in metastatic breast cancer

M Bredemeier, P Edimiris, P Mach, M Kubista… - Clinical …, 2017 - academic.oup.com
BACKGROUND Circulating tumor cells (CTCs) are thought to be an ideal surrogate marker
to monitor disease progression in metastatic breast cancer (MBC). We investigated the …

ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic …

I Chebouti, JD Kuhlmann, P Buderath, S Weber… - …, 2016 - pmc.ncbi.nlm.nih.gov
Background We recently showed that the presence of ERCC1+ CTCs is an independent
predictive biomarker for platinum-resistance and poor prognosis of ovarian cancer. The goal …